RT Journal Article
SR Electronic
T1 Predicting critical illness on initial diagnosis of COVID-19: Development and validation of the PRIORITY model for outpatient applicability
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.27.20237966
DO 10.1101/2020.11.27.20237966
A1 Miguel Martinez-Lacalzada
A1 Luis Adrián Viteri-Noël
A1 Luis Manzano
A1 Martin Fabregate-Fuente
A1 Manuel Rubio-Rivas
A1 Sara Luis Garcia
A1 Francisco Arnalich Fernández
A1 José Luis Beato Pérez
A1 Juan Antonio Vargas Núñez
A1 Elpidio Calvo Manuel
A1 Alexia-Constanza Espiño
A1 Santiago J. Freire Castro
A1 Jose Loureiro-Amigo
A1 Paula Maria Pesqueira Fontan
A1 Arturo Artero
A1 Ana María Álvarez Suárez
A1 Andrea Silva Asiain
A1 Beatriz García López
A1 Jairo Luque del Pino
A1 Jaime Sanz Cánovas
A1 Paloma Chazarra Pérez
A1 Gema María García García
A1 Jesús Millán Núñez-Cortés
A1 José Manuel Casas Rojo
A1 Ricardo Gómez Huelgas
A1 for the SEMI-COVID-19 Network
YR 2020
UL http://medrxiv.org/content/early/2020/12/01/2020.11.27.20237966.abstract
AB OBJECTIVE To develop and validate a prediction model, based on clinical history and examination findings on initial diagnosis of COVID-19, to identify patients at risk of critical outcomes.DESIGN National multicenter cohort study.SETTING Data from the SEMI (Sociedad Española de Medicina Interna) COVID-19 Registry, a nationwide cohort of consecutive COVID-19 patients presenting in 132 centers between March 23 and May 21, 2020. Model development used data from hospitals with ≥300 beds, and validation used those from hospitals with <300 beds.PARTICIPANTS Adults (age ≥18 years) presenting with COVID-19 diagnosis.MAIN OUTCOME MEASURE Composite of in-hospital death, mechanical ventilation or admission to intensive care unit.RESULTS There were 10,433 patients, 7,850 (main outcome rate 25.1%) in the model development cohort and 2,583 (main outcome rate 27.0%) in the validation cohort. The clinical variables in the final model were: age, cardiovascular disease, moderate or severe chronic kidney disease, dyspnea, tachypnea, confusion, systolic blood pressure, and SpO2 ≤93% or supplementary oxygen requirement at presentation. The model developed had C-statistic of 0.823 (95% confidence interval [CI] 0.813 to 0.834) and calibration slope of 0.995. The external validation had C-statistic of 0.792 (95% CI, 0.772 to 0.812) and calibration slope of 0.872. The model showed positive net benefit in terms of hospitalizations avoided for the predicted probability thresholds between 3% and 79%.CONCLUSIONS Among patients presenting with COVID-19, easily-obtained basic clinical information had good discrimination for identifying patients at risk of critical outcomes, and the model showed good generalizability. A model-based online prediction calculator provided with this paper would facilitate triage of patients during the pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research did not receive external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Authors declare that all relevant ethical guidelines have been followed, all necessary IRB and/or ethics committee approvals have been obtained, all necessary patient/participant consent has been obtained and the appropriate institutional forms archived.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available on request from the SEMI-COVID-19 Registry Coordinating Center, S&H Medical Science Service and the corresponding author, [LM].